+91-9666438880
indiaord@gmail.com
IORD – Indian Organization for Rare DiseasesIORD – Indian Organization for Rare DiseasesIORD – Indian Organization for Rare DiseasesIORD – Indian Organization for Rare Diseases
  • Home
  • About Us
    • Management Committee
    • Advisory Board
    • Newsletters
    • Newsletter Subscription
  • Rare Diseases
  • Research
  • Services
  • Donate
  • Gallery
    • Photo Gallery
      • World Rare Disease Day – 2023
      • World Rare Disease Day 2020
    • Video Gallery
      • World Rare Disease Day – 2020
      • World Rare Disease Day – 2019
      • World Rare Disease Day – 2018
  • Blog
  • Contact Us

Mistletoe: Introduction and Basis for use in Cancers

    Home IORD Updates Mistletoe: Introduction and Basis for use in Cancers
    NextPrevious
    Dr P. Harihara Murthy

    Mistletoe: Introduction and Basis for use in Cancers

    By IORD | IORD Updates, News, Rare Disease News | 0 comment | 7 November, 2022 | 0

    (This is an abridged version of the presentation delivered by Dr P. Harihara Murthy, MBBS, MS, DLO, Sr. Consultant E.N. T., Head & Neck Surgeon & Anthroposophic Physician, Swasthya Niketan, Koramangala Bangalore, Murthy Health & Research Centre, Koramangala, Bangalore & Apollo Spectra Hospital, Koramangala, Bangalore at the ‘Dr N Srinivasa Rao Memorial Symposium – Rare Diseases & Alternative Treatment’ organized by IORD at Hyderabad on 25th June.)

    Introduction:

    Arbudha Roga – illustrated by the ancient Indian Surgeon in great detail in the Sushrutha Samhitha predating the Christian era, where it has been described as a disease which has no definitive cure. To date, we have had in modern medicine many modalities of treatment and many medicines that have been used with very variable results and side effects. We are in the ongoing study of an ill-understood disease and the difficult treatment for it.

    Properties of the Mistletoe Plant:

    Mistletoe (Viscum album L) is an unusual plant with many unusual properties. First, it does not grow on the ground, it grows in the bark of various types of trees high up in the air amongst the branches of the host tree. Second, instead of going dormant or dying during the winter-time, it bears its fruit, a small white berry, in the snow and ice of winter. Third, it stores chlorophyll down into its roots and is green all year long and is indifferent to light. Thus, it is neither geotropic nor phototropic. 

    Rationale for Remedy:

    The extracts are unique in that the juices of the summer and winter plants must be combined, as the summer plant is at the height of its vegetative growth, and the winter plant has in some ways concluded its life rhythm by combining these two extracts and thus these two different components of life, an anti-cancer treatment is created.

    Cancer, then, can be viewed as the cold, sclerotic forces of the body becoming dominant to the other two aspects, instead of being in harmony with them. The absence of the balancing of the hardening sclerotic forces and the warming inflammatory processed

    The Four-Fold Approach:

    Humans are viewed as having four different levels of being, or existence. First is the physical body. The physical realm is the most basic; it is what we share with all plants, animals, rocks and minerals (it represents the physical world; the element earth).      

    Second is the life-forces body, or, etheric body; it is what we share with plants and animals (it takes hold of the physical world through the element water). 

    The third is the astral body, or soul (it takes hold of the physical world through the element air). Man, and animals are bestowed with consciousness; they are not fixed in one place and they are all capable of feelings, we all share this body. 

    The last is that which humans have alone. Through the effects of the Ego, man becomes his typical human shape, and becomes an erect being. Human beings have an ego (spirit) and are therefore self-conscious. The ego takes hold of the physical through the element of fire or warmth.

    Pathogenesis:

    When a person develops cancer, it is thought this is because their Ego has left the cells of their body to a certain extent, and have lost their ability for differentiation, thus a type of downward regression occurs (normal cells regress into a more embryonic state) the more they regress in this way, the more undifferentiated they become, expressing their more aggressive growth pattern, and tendency to metastasize. 

    Interestingly, the ego- and astral forces bringing consciousness and self-consciousness and which work through the nerve-sense system downwards, may become too destructive and, by flowing from the head down into the metabolic limb system, induce inhuman growths.

    There, Steiner declared, these forces tend to form swellings, and malformations, thus leading to carcinomatous growths 

    Finally, anthroposophy seeks to explain cancer as an effect of spiritual disharmony as well. The rise of cancer today is likely a direct consequence of the current development of mankind as a whole.

    Our current movement towards the separation of the spirit from the body and intellectualization has extended consciousness into realms of bodily activities that were formerly unconscious or were controlled in rhythmic subconsciousness. 

    Increase in the carcinomatous diseases in our day is paralleled by the widespread development of the forces of the intellect. Similar to the cold, sclerotic body moving downward, the movement of the intellect into other parts of the human being has led to the distortion of balance in the physical organism.

    The intellect has grown out of balance in the human soul and spirit. 

    The powers of Thinking (Ego), having lost the sense of their true relation to the spirit, have associated themselves in purely Intellectual Thinking (Ego-Astral) with the instincts of Life and growth (the Etheric) in the lower bodily nature of man – as centred on and satisfied by the material work – and the feeling-life arising out of that lower nature. Thus, the origin of the physical imbalance called disease would be related to the human spiritual imbalance – scientific materialism.

    MISTLETOE: HOST TREES

    Apple: Viscum Mali

    Elm: Viscum Ulmi

    Fir: Viscum Abietus

    Pine: Viscum Pini

    Oak: Viscum Quercus

    Cytotoxic Properties:

    Lectins: ML-1, ML-2, ML-3, and Viscum album chitin-binding agglutinin have been identified in mistletoe extracts. ML-1 (or viscumin) may be responsible for many of mistletoe’s biological effects. The molecular structure of ML-1 consists of an alpha chain and a beta chain, which can be separated from one another. 

    Each chain type appears to mediate a subset of the activities described for the intact lectin. Cytotoxicity is associated mainly with the alpha chain. In laboratory studies, the ML-1 alpha chain has been coupled to monoclonal antibodies to produce immuno-toxins that target and kill specific cell types. 

    The beta chain of ML-1 is responsible for binding to the surface of a target cell. Studies of mistletoe lectin binding to cancer cells have examined whether the extent of cell binding can predict disease outcome or survival. Laboratory studies have shown that mistletoe extracts can stimulate the activity of white blood cells in vitro and cause them to release molecules thought to be important for anticancer immune responses. Mistletoe extracts have demonstrated cytotoxic activity against a variety of mouse, rat and human cancer cells in vitro.

    When a laboratory method was used to selectively deplete ML-1 from Viscum album extracts, their cytotoxic and immune-system-stimulating properties were markedly reduced.

    Cancer Fighting Properties: Mistletoe is a biological response modifier. It 

    a) Stimulates the thymus, the chief regulator of cellular immune reactions. 

    b) Increases the number of granulocytes, which are the scavenger white blood cells that consume invading antigens, Protects the D N A in WBCs including those exposed to radiation and Chemo-therapeutic drugs

    c) Immune-system-enhancing cytokines, such as interleukin-1, interleukin-6 & TNF-α (tumour necrosis Factor-alpha)

    d) Mistletoe elevates the number of immuno-competent white cells and activates natural killer cells capable of spontaneously destroying tumour cells.)

    e) Mistletoe extract also contains biologically active proteins (lectins) and other substances that have exhibited powerful anti-tumour action in animal and cell-culture experiments

    f) Enhances phagocytosis, the white blood cells’ ability to ingest and destroy other cells or foreign material.    

    Apoptosis of cancer cells is a very well-established result of mistletoe. It also prevents neo-vascularization that is required for the proliferation of solid tumours.

    Results:

    Mistletoe has been used mainly as: 

    • Adjunct to surgery
    • Radiation
    • Chemotherapy

    Mistletoe therapy improves the survival rates for cancers of the following:

    • Cervix
    • Ovaries
    • Brain
    • Vagina
    • Breast
    • Prostate
    • Stomach
    • Colon
    • Lung 
    • Slowing of tumour growth
    • Occasional regression of tumours
    • Remission

    The best results have been obtained in the treatment of solid tumours both before and after surgery and radiotherapy. 

    Survival Rates & Pre-Op:

    Mistletoe therapy improves the survival rates for cancers of the cervix, ovaries, vagina, breast, stomach, colon, bone and lung as well as other locations. 

    Preoperative mistletoe therapy is given for ten to fourteen days before surgery. It aims to help prevent the metastatic spread of cancer due to surgical intervention. 

    Post-Op Treatment:

    Post-operative treatment is ideally begun immediately after surgery or radiotherapy. This follow-up treatment reportedly reduces the risk of recurrence after surgery or radiation. 

    Mistletoe is usually administered by subcutaneous injection at or near the tumour site. A typical course of treatment consists of fourteen injections given in increasing concentrations. 

    Administration:

    Injections –  

    • Sub cutaneous
    • Intravenous
    • Intra Pleural                                                                                                              
    • Intra tumoral
    • Intra peritoneal
    • Oral Medication

    Brands of Mistletoe:

    • Abnoba VISCUM
    • Eurixor
    • Helixor
    • Iscador
    • Isorel (Vysorel)
    • Iscucin
    • Lektinol (Plenosol)

    SIDE EFFECTS:

    • Inflammation
    • Local rashes
    • Lymphadenopathy
    • Headache
    • Fever
    • Chills
    • Reversible hepatotoxicity
    • Raised intracranial tension
    • Anaphylactic shock

    Hospitals Using Mistletoe: 

    Clinic in LIFE Gartenweg 5-6 07973 Greiz

    Naturopathy Königstr. 63 14109 Berlin-Wannsee

    Sonnenberg Klinik Hardtstr. 13 37242 Bad Sooden-Allendorf

    Vita Natura clinic Altschloßstr. 1 66957 Eppenbrunn

    BioMed Klinik Bad Bergzabern table Str 5-8. 76887 Bad Bergzabern

    Hospital for Natural Healing Sanatorium Platz 2 81545 München

    Waldhausklinik Deuringen GmbH Sandbergstr. 47-49 86391 Stadtbergen

    Hufeland Clinic Löffelstelzer Str 1-3. 97980 Bad Mergentheim

    Medical Center Kalden Mommsenstr. 57 10629 Berlin

    Anthroposophic hospitals

    Havelhöhe hospital clinic for anthroposophic medicine advanced Kladower Damm 21 14089 Berlin

    Asklepios Hospital Hamburg West Station for Integrative Medicine Suurheid 20 22559 Hamburg

    Herdecke Community Hospital Gerhard-Kienle-Weg 4 58313 Herdecke / Ruhr

    Filderklinik In Haberschlai 7 70794 Filderstadt (Bonlanden) Stuttgart

    Paracelsus Hospital Burghaldenweg 60 75378 Bad Liebenzell-inferiority Hardt

    Clinic Lahnhöhe 

    Regional Center for Psychosomatic Medicine and holistic medicine (only for patients who require additional psychotherapy) Am Kurpark 1 56112 Lahnstein

    Klinik Arleshiem, Arleshiem, Switzerland

    Paracelcus Spital, Zurich, Switzerland

    Haus Am Stalten, Germany

    Anthroposophic sanitarium or rehabilitation hospitals

    Rehabilitation Clinic, Schloss Hamborn, Schloss Hamborn 85

    Clinics Sonneneck Kanderner Straße 18 79410 Badenweiler Sanatorium house Stalten Staltenweg 25 79585 Steinen

    Naturopaths Archaeus – Institute of Naturopathy Werner Schmötzer Klingenhaldenweg 2372175 Dornhan

    Dr N Srinivasa Rao Memorial Symposium, Mistletoe Treatment for Rare Diseases, rare disease awareness, Rare Diseases

    IORD

    More posts by IORD

    Related Post

    • Clinical assessment of European Mistletoe Extracts (Viscum Album) along with Homeopathy in III and IV stage cancers

      Role of Mistletoe with Homeopathy in III & IV Stage Cancers: By Dr Ravi Doctor

      By IORD | 0 comment

      (This is an abridged version of the presentation titled “Clinical Assessment of European Mistletoe Extracts (Viscum Album) Along with Homeopathy in III and IV Stage Cancers”. It was delivered by Dr Ravi Doctor, Associate ProfessorRead more

    • RARE DISEASES & ALTERNATE MEDICINE: Dr I. Rajyalakshmi

      RARE DISEASES & ALTERNATE MEDICINE: Dr I. Rajyalakshmi

      By IORD | 0 comment

      (This is an abridged version of the presentation delivered by Dr I. Rajyalakshmi Homeopathy Practitioner, Hyderabad at the ‘Dr N Srinivasa Rao Memorial Symposium – Rare Diseases & Alternative Treatment’ organized by IORD at HyderabadRead more

    • Dr N Srinivasa Rao Memorial Symposium - Rare Diseases & Alternative Treatment'

      ‘25% of World’s Rare Disease Patients are in India’

      By IORD | 0 comment

      India has the largest rare disease population in the world, said speakers attending the ‘Dr N Srinivasa Rao Memorial Symposium – Rare Diseases & Alternative Treatment’ at Hyderabad on 25th June, saying it is homeRead more

    • Prof. Ramaiah Muthyala (left, sitting) discussing innovative solutions for rare diseases at the 2025 World Orphan Drug Congress in Boston. With a focus on policy reforms and access to affordable medications, the panel addressed the urgent need for systemic change in rare disease care globally

      Prof. Ramaiah Muthyala Calls for Policy Reforms at World Orphan Drug Congress-2025

      By IORD | 0 comment

      Prof. Ramaiah Muthyala discussed challenges and solutions for rare disease access at the 2025 World Orphan Drug Congress in Boston. He highlighted the global economic burden of rare diseases and the unique barriers in low-Read more

    • Prof. Ramaiah Muthyala, CEO & President of IORD, inaugurates the World Rare Disease Day 2025 conference in Vijayawada by lighting the ceremonial lamp in the presence of dignitaries.

      World Rare Disease Day 2025: IORD Advocates for Policy & Awareness

      By IORD | 0 comment

      Vijayawada: The Indian Organization for Rare Diseases (IORD), a non-profit advocacy body, convened a critical conference titled “RAISE THE AWARENESS – RARE DISEASES: Advocate Public Policy, Promote Diagnosis, Treatment & Social Services” at Fortune MuraliRead more

    NextPrevious

    Categories

    • ANI
    • Deccan Chronicle
    • Economic Times
    • Eenadu
    • Events
    • IORD in News
    • IORD Updates
    • News
    • Pharmabiz.com
    • Rare Disease News
    • Telangana Today
    • The Hans India
    • The Hindu
    • The Pioneer
    • Times Now
    • Times of India
    • Uncategorised
    • Vaartha

    Recent Posts

    • My Battle with Porphyria: Why Jagruti Urges Nationwide Access to Hemin
    • May 2025: Rare Disease Updates, New Discoveries, Diagnostics, and Therapies
    • 78th WHA Takes Historic Step with Rare Diseases Resolution, 10-Year Global Plan Approved
    • India’s Rare Disease Crisis: Why Grassroots Solutions Are Urgently Needed
    • Advancing Rare Disease Awareness in India: Dr. Ramaiah Muthyala’s Strategic Insights

    Archives

    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • September 2024
    • July 2024
    • June 2024
    • May 2024
    • March 2024
    • February 2024
    • December 2023
    • October 2023
    • July 2023
    • June 2023
    • May 2023
    • April 2023
    • March 2023
    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021
    • October 2021
    • September 2021
    • July 2021
    • May 2021
    • April 2021
    • November 2020
    • March 2020
    • February 2020
    • January 2020
    • February 2019
    • January 2018
    • September 2015

    Follow Us

    IORD

    Indian Organization For Rare Diseases (IORD), a not-for-profit umbrella organization represents interests of all stakeholders of Rare Diseases in India including individual patients, patient support groups, health policy advocates and health care providers.

    RARE DISEASES

    • Rare Blood Diseases
    • Rare Heart Diseases
    • Rare Fungal Diseases
    • Rare Kidney Diseases
    • Rare Newborn Diseases
    • more...

    SERVICES

    • Research
    • Let's Come Together
    • Partner With Us
    • Volunteers
    • Privacy Policy
    • Sitemap

    CONTACT US

    Indian Organization For Rare Diseases
    Reg. Office (India): Plot 397, Road 22b, Jubilee Hills, Hyderabad (Telangana) 500033, Telangana, India

    Phone: +91-9666438880

    Email: indiaord@gmail.com

    © 2020 Indian Organization For Rare Diseases | All Rights Reserved. Powered By Digital Dynamics
    • Home
    • About Us
      • Management Committee
      • Advisory Board
      • Newsletters
      • Newsletter Subscription
    • Rare Diseases
    • Research
    • Services
    • Donate
    • Gallery
      • Photo Gallery
        • World Rare Disease Day – 2023
        • World Rare Disease Day 2020
      • Video Gallery
        • World Rare Disease Day – 2020
        • World Rare Disease Day – 2019
        • World Rare Disease Day – 2018
    • Blog
    • Contact Us
    IORD – Indian Organization for Rare Diseases